Mohamed Sikkander Abdul Razak: Recent Breakthroughs in Stem Cell Therapy for Diabetes Treatment
Mohamed Sikkander Abdul Razak, Professor at GKM College of Engineering Technology, shared a post on LinkedIn about the recent article by Manikandan S. et al, adding:
“Recent breakthroughs in stem cell therapy are offering new hope for diabetes patients.
Chinese scientists have successfully reversed type-2 diabetes in a patient using stem-cell therapy, where healthy pancreatic cells were transplanted to mimic insulin regulation.
This innovative treatment involves taking stem cells from the patient or a donor, reprogramming them into insulin-producing pancreatic islet cells, and transplanting them into the patient’s abdomen.
The transplanted cells then function like healthy pancreatic beta cells, sensing blood glucose levels and releasing insulin as needed.
While this is a groundbreaking development, experts stress that larger clinical trials are needed to confirm long-term safety and effectiveness.
Vertex Pharmaceuticals is also conducting Phase 3 trials for an islet cell therapy, with regulatory submissions expected in 2026.
Stem cell therapy has shown promise in reducing insulin requirements in type 2 diabetes patients, but more research is needed to confirm its effectiveness and safety for type 1 diabetes.”
Title: Efficacy and safety of stem cell therapy in patients with Diabetes Mellitus – a systematic review and meta-analysis
Authors: Manikandan S, Roopa Hariprasad, Bhavani Shankara Bagepally
Read the Full Article on Springer Nature
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS